Sidney Carter, MD (1912–2005)
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Dr. Sidney Carter, one of the most eminent and beloved of neurologists and a founder of child neurology, died on Sunday, January 16th, on Cape Cod. He was 92 years old.
Dr. Carter was born in Boston and attended Dartmouth College. He received his medical degree from Boston University in 1938. He interned at St. Mary’s Hospital in Waterbury, CT and then trained in psychiatry in 1939 to 1940 at the Westboro State Hospital in Westboro, MA. In 1941, he started his residency in neurology on the Harvard Unit at Boston City Hospital, where Houston Merritt had recently been appointed Acting Director, following the departure of Tracy Putnam to the Neurologic Institute of New York. In addition to Merritt, Carter worked closely with Raymond Adams, then also at the Boston City Hospital. In 1943, Derek Denny-Brown was named Director of the Neurology Service and, 2 years later, Merritt left to direct Columbia’s neurology program at Montefiore Hospital in the Bronx. Carter had the distinction of being Merritt’s last chief resident at Boston City, and Denny-Brown’s first. During World War II, Carter joined other physicians from the Boston City Hospital at the Seventh General Army Hospital in England, where he was assistant chief of the neuropsychiatric section and the principal neurologic consultant for army casualties.
His military career had …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Sidney Carter, MD (1912–2005)
- Sheldon Wolf, UCLA School of Medicine, 300 UCLA Medical Plaza, Los Angeles, CA 90095-6975[email protected]
Submitted June 29, 2005
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Views & Reviews
Eliminating barriers to personalized medicineLearning from neurofibromatosis type 1David H. Gutmann et al.Neurology, June 27, 2014 -
Articles
Brain volume in children with neurofibromatosis type 1Relation to neuropsychological statusB.D. Moore III, J.M. Slopis, E.F. Jackson et al.Neurology, February 22, 2000 -
Articles
Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis 1 in childrenK. DeBella, K. Poskitt, J. Szudek et al.Neurology, April 25, 2000 -
Article
Current status and recommendations for biomarkers and biobanking in neurofibromatosisC. Oliver Hanemann, Jaishri O. Blakeley, Fabio P. Nunes et al.Neurology, August 15, 2016